"I gladly hand over to Roy Jakobs in the knowledge that he brings the experience, energy, and commitment to take Philips on the path forward." According to Philips, Jakobs brings a strong international, operation, and transformational track record, as well as a deep understanding of the company. He took over the voluntary recall notification for the Respironics devices and booked substantial progress in finding solutions for patients as fast as possible, the company said. Jakobs said he is "delighted" by his appointment to CEO, which will be confirmed at a shareholders' meeting on September 30. "I aim to build on the company's strong foundation as a purpose-driven health technology leader with deep innovation and clinical expertise, to serve the needs of patients and consumers today and in the future."